HighTower Advisors’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.7K Hold
12,150
﹤0.01% 3564
2025
Q1
$17.7K Hold
12,150
﹤0.01% 3460
2024
Q4
$25.9K Sell
12,150
-17,500
-59% -$37.3K ﹤0.01% 3437
2024
Q3
$82K Sell
29,650
-906
-3% -$2.51K ﹤0.01% 3312
2024
Q2
$72K Hold
30,556
﹤0.01% 3217
2024
Q1
$137K Buy
30,556
+5,000
+20% +$22.4K ﹤0.01% 3053
2023
Q4
$82K Sell
25,556
-30,303
-54% -$97.2K ﹤0.01% 3186
2023
Q3
$176K Sell
55,859
-468
-0.8% -$1.48K ﹤0.01% 2935
2023
Q2
$279K Sell
56,327
-532
-0.9% -$2.64K ﹤0.01% 2598
2023
Q1
$280K Sell
56,859
-488
-0.9% -$2.4K ﹤0.01% 2492
2022
Q4
$361K Sell
57,347
-10,712
-16% -$67.4K ﹤0.01% 2323
2022
Q3
$734K Hold
68,059
﹤0.01% 1777
2022
Q2
$776K Buy
68,059
+17,500
+35% +$200K ﹤0.01% 1779
2022
Q1
$462K Sell
50,559
-30
-0.1% -$274 ﹤0.01% 2208
2021
Q4
$753K Sell
50,589
-1,220
-2% -$18.2K ﹤0.01% 1908
2021
Q3
$1.33M Buy
51,809
+5,500
+12% +$142K ﹤0.01% 1496
2021
Q2
$1.21M Sell
46,309
-2,000
-4% -$52.2K ﹤0.01% 1523
2021
Q1
$1.7M Hold
48,309
0.01% 1218
2020
Q4
$1.22M Buy
48,309
+3,850
+9% +$97.1K 0.01% 1157
2020
Q3
$1.68M Sell
44,459
-1,826
-4% -$68.9K 0.01% 952
2020
Q2
$1.98M Sell
46,285
-10,160
-18% -$434K 0.01% 805
2020
Q1
$1.1M Buy
+56,445
New +$1.1M 0.01% 957
2019
Q4
Sell
-23,140
Closed -$630K 2171
2019
Q3
$630K Buy
23,140
+11,738
+103% +$320K ﹤0.01% 1396
2019
Q2
$306K Buy
+11,402
New +$306K ﹤0.01% 1784